Dr. Jack Levy, MD

Dr. Levy practices at Metropolitan Dermatology in Newton, New Jersey.

Dr. Levy's NPI, 1720512049, was assigned on April 13, 2017. Dr. Levy graduated from Weill Cornell Medicine in 2016. Dr. Levy holds New York license 309233-01.

Dr. Levy's primary practice is Metropolitan Dermatology, at 136 Woodside Ave, Newton, NJ 07860 in Sussex County. The practice phone is (732) 574-1399.

Dr. Levy's primary practice is Metropolitan Dermatology in Newton, New Jersey. Dr. Levy is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Levy to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levy practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Levy's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Levy is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Levy's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives, itchy rashes and rash among the conditions Dr. Levy treats.

CMS data shows 625 Medicare services from Dr. Levy across 17 procedure codes in 2024, for 198 Medicare patients. Medicare paid $109,726 for them. Every service was in an office.

CMS counts 198 Medicare patients who saw Dr. Levy in 2024. The largest group is 65 to 74, with 90 patients. 68% of them have high cholesterol, and 59% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Levy's median patient age at 53, with 48% women.

In 2024, Dr. Levy wrote 342 Medicare Part D claims for 152 patients. 97% of them were for generic drugs. CMS names the drug for 244 of them, across 8 drugs with 11 or more claims each, at $4,004 in total drug cost. In 2023, CMS named 341 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Levy for performance year 2024, reported through an alternative payment model (APM). Dr. Levy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Levy as offering telehealth. CMS counts 38 procedures of melanoma (skin cancer) excision by Dr. Levy, more than 83% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Levy in 2016. Dr. Levy's most frequent co-authors are Mark E. Burnett, MD and Samuel J. Mann, MD.

CMS Open Payments shows 14 general payments to Dr. Levy from 11 drug and device companies from 2021 to 2023. Food and beverage make up the largest share, 100% of the total. Amgen Inc. paid the most, $47.

Dr. Levy graduated from Weill Cornell Medicine in 2016.

Dr. Levy is in network with 17 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.